Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.
about
Ivabradine in combination with beta-blocker improves symptoms and quality of life in patients with stable angina pectoris: results from the ADDITIONS study.Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for ArthriPredictors of health-related quality of life in patients at risk for cardiovascular disease in European primary care.Predicting health utilities for children with autism spectrum disorders.Cost-effectiveness of the chronic disease self-management program: implications for community-based organizations.Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.Estimation of utility values from visual analog scale measures of health in patients undergoing cardiac surgery.Impact of angina frequency on health utility values of patients with chronic stable anginaEvaluation of content on EQ-5D as compared to disease-specific utility measures.Relative efficacy of antianginal drugs used as add-on therapy in patients with stable angina: A systematic review and meta-analysis.The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.Health-related quality of life in adult inpatients affected by anorexia nervosa.Chronic pain patients can be classified into four groups: Clustering-based discriminant analysis of psychometric data from 4665 patients referred to a multidisciplinary pain centre (a SQRP study).Differences in utility elicitation methods in cardiovascular disease: a systematic review.
P2860
Q30318221-62A8850F-5ECE-4BC7-91C4-CB995C5D9D03Q31043286-799C688F-4498-465D-B1BF-BF65EE7A16C4Q34117492-F27002F6-0C8A-44B1-9887-59F9F5E1F3BBQ34735353-843D46B4-0821-4A3A-B499-E80C3771BA51Q35540192-CAB2E159-28A8-4FB2-A966-13EDE880E7FCQ36258672-6B4454AD-3D30-473C-8B90-B699E6BEFEECQ37487742-FD7D446D-531B-49C0-B0D4-8A0CF84D8241Q37716587-16C1D51B-2C5D-40C2-A1F6-B5620E711455Q38021389-6CC4FD32-642F-45B0-96C5-0FECAB8DCA1FQ38207815-CA214885-1356-4002-B8CD-1E4EE550C44AQ38558706-1947B389-2410-4A84-8C59-609B4BAEC182Q48074344-0CA947D7-C1FE-4DD7-BA73-A830FEC9B3A4Q50114401-88BD01B0-A7A4-4C6D-8733-7F4EBA4CFC80Q50129904-C5D8A556-C8CE-4314-8E3C-32C5613442F3
P2860
Mapping of the EQ-5D index from clinical outcome measures and demographic variables in patients with coronary heart disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@ast
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@en
type
label
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@ast
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@en
prefLabel
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@ast
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@en
P2860
P356
P1476
Mapping of the EQ-5D index fro ...... s with coronary heart disease.
@en
P2093
Martin J Buxton
Matthew T Dyer
P2860
P2888
P356
10.1186/1477-7525-8-54
P577
2010-06-04T00:00:00Z
P5875
P6179
1003853920